• Aucun résultat trouvé

Intestinal pathogenic escherichia coli: Insights for vaccine development

N/A
N/A
Protected

Academic year: 2021

Partager "Intestinal pathogenic escherichia coli: Insights for vaccine development"

Copied!
18
0
0

Texte intégral

Loading

Figure

TABLE 1 | Summary of the most promising vaccine candidates against EHEC and ETEC.
TABLE 1 | Continued
FIGURE 1 | Schematic representation of the virulence factors used as vaccine candidates in InPEC

Références

Documents relatifs

Figures 4b-c show that the lower Ni content or the Ru one, used as co-catalysts, are beneficial (electronic and/or strain effects) to increase the activity of Pd-based catalysts

Taking into account the direction of the local magnetic field the flow direction of the protons implies that they are coming from the expected reconnection site (magnetopause close

Using the Medical Information Mart for Inten- sive Care-III (MIMIC-III) a critical care database that was developed and maintained by the Laboratory for Computational Physiology

des taux d’entrée et de sortie, augmente de 0,2 point dans les établissements de 10 salariés ou plus, après une baisse de 0,2 point au trimestre précédent qui succé- dait à

Therefore, we investigated the time courses of plasma parameters related to calcium homoeostasis (calcium, phosphate, calcitriol, the bone resorption marker CrossLaps ® and the

Differential methyla- tion due to Lrp is, however, not involved in the regulation of K99 expression, as it is for the fimbriae of the P regulatory family. The mechanism

Jean-Rémy Sadeyen, Zhiguang Wu, Holly Davies, Pauline M van Diemen, Anita Milicic, et al.. Immune responses associated with homologous protection conferred by commercial vaccines

Young pigs consuming lysozyme transgenic goat milk are protected from clinical symptoms of enterotoxigenic Escherichia coli infection. Cooper CA, Maga EA, Murray JD (2014)